🇺🇸 TOT'HEMA in United States
6 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 6
Most-reported reactions
- Lung Disorder — 1 report (16.67%)
- Pancreatitis Acute — 1 report (16.67%)
- Pulmonary Oedema — 1 report (16.67%)
- Syncope — 1 report (16.67%)
- Torsade De Pointes — 1 report (16.67%)
- White Blood Cell Count Increased — 1 report (16.67%)
Other Hematology approved in United States
Frequently asked questions
Is TOT'HEMA approved in United States?
TOT'HEMA does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for TOT'HEMA in United States?
Laboratoire Innotech International is the originator. The local marketing authorisation holder may differ — check the official source linked above.